The annual Phillip and Ruth Hettleman Prizes for Artistic and Scholarly Achievement have been awarded to four associate professors who exemplify groundbreaking and innovative research.
James H. Doroshow, M.D.
Director, Division of Cancer Treatment and Diagnosis
As the National Cancer Institute (NCI) Deputy Director for Clinical and Translational Research, Dr. James H. Doroshow works closely with the NCI director and other deputy directors to carry out NCI’s mission, particularly as it relates to clinical trials and translational investigations.
In early 2020, as part of NCI’s response to the COVID-19 pandemic, Dr. Doroshow led the rapid launch of the NCI COVID-19 in Cancer Patients Study (NCCAPS). In this natural history study, researchers will follow 2,000 individuals with cancer and COVID-19 and collect clinical information and biospecimens over two years. Findings will inform our understanding of COVID-19’s impact on patients with cancer, as well as cancer’s impact on the course of COVID-19, and how both can best be managed.
Date Time
Shaping National Public Health Policies With Science
CU Anschutz experts sit on NASEM committees, offering a ‘critical translational step’ in turning science into policy
Professors and faculty members at most research universities spend the bulk of their professional time in well-known academic pursuits: teaching, researching, collaborating with colleagues, and leading the next generation of experts in their respective fields. Less apparent are hundreds of hours some volunteer to present at conferences, provide testimony for policies, and collaborate on scientific committee work, publish papers, and review others’ work for publication.
One distinguished but often less publicized volunteer effort is chairing or sitting on a variety of committees within the National Academies of Sciences, Engineering and Medicine (NASEM). At the Colorado School of Public Health (ColoradoSPH), many faculty volunteer with NASEM committees, and in this role, they help to shape policies